SEP 04, 2018 04:06 PM PDT

Cellular Mechanism Inspires Bone-Forming Drugs

WRITTEN BY: Nouran Amin

Credit: National Osteoporosis Foundation

There exists a certain amount of therapeutic drugs that treat osteoporosis by promoting bone formation in comparison to only a few drugs used to suppress bone resorption. Now, according to a study published in Nature Communications, researchers at Kumamoto University have discovered a gene called ‘SIRT7’ which is crucial for bone formation. SIRT7 was found by researchers to be involved in a mechanism that activates genes essential for bone formation and thus researchers are hoping to find new drugs that can target such a pathway known as 'SIRT7-regulated osteoblastogenesis pathway'. These drugs may work to treat decreased osteogenesis and osteoporosis.

Osteoporosis is a disease caused by a decrease in bone mass and bone quality that allows bones to easily fracture. The most leading cause of osteoporosis is aging and is “estimated that around 200 million people are affected worldwide”. To learn more about osteoporosis, watch this video below:

A balanced living tissue, bone is always broken down (bone resorption) and always built back up (bone formation). If the bone gets out of balance such as bone resorption exceeding bone formation then bone density is reduced leading to osteoporosis. There are several medicines on the market available to treat osteoporosis, however, the number of drugs that promote bone-building is not as much as drugs that suppress bone resorption. Therefore, developing therapeutic agents that regenerate bones was the main priority of the researchers.

The research consisted of experiments on mice lacking the SIRT7 which meant that these mice had a reduced bone mass. Using an instrument, bone morphometry analysis was performed that showed bone formation and the number of osteoblasts (bone-building cells) was reduced. The scientists then obtained similar results from osteoblast-specific SIRT7 lacking mice. Therefore, the research showed that (osteoblast-specific) SIRT7 is crucial for forming bone. "In situations where SIRT7 does not work sufficiently, such as in an older individual, osteoblast formation is impaired due to low SP7/Osterix transcriptional activity. We believe that this decreased osteogenesis is associated with osteoporosis," said study leader Dr. Tatsuya Yoshizawa of Kumamoto University. "Our results, show that the regulatory pathway of SIRT7 -- SP7 / Osterix is a promising target for new therapeutic agents to treat decreased osteogenesis and osteoporosis."

Source: Kumamoto University, Nature Communications

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Controlling The Release of Drug Components Using Artificial DNA
Studies carried out at the Technical University of Munich (TUM) can allow nanapoarticles to be released in pre-defined sequence at specified times. Using a...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Lab-on-a-chip Advances Search for Anti-Clotting Drugs
A novel ‘lab-on-a-chip’ the size of a postage stamp could soon advance the developments of safer anti-clotting drugs for heart attack and strok...
OCT 13, 2019
Genetics & Genomics
OCT 13, 2019
New Gene Editing Technology to Combat Hereditary Diseases
Until recently, many types of gene-editing methods were unable to target critical parts of DNA. Now however, researchers at the Salk Institute have develop...
OCT 13, 2019
Genetics & Genomics
OCT 13, 2019
Can Lifestyle Changes Switch Off Dementia Genes?
Around 50 million people have dementia worldwide, with 10 million new cases emerging each year (World Health Organization: 2019). Most prominent in people ...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Injectable Hydrogel Found Safe for Heart Repair
The first successful in-human clinical trial of an injectable hydrogel that aims to repair heart damage and restore cardiac function was recently conducted...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Genital Herpes Vaccine Works in Rodents
A recent vaccine was developed by scientists at Perelman School of Medicine at the University of Pennsylvania that protects against genital herpes. The vac...
Loading Comments...